BRNS vs LW · $38.2M cap vs P/E 21, rev $6.61B
Barinthus Biotherapeutics plc (BRNS) versus Lamb Weston Holdings Inc (LW) — a side-by-side from cached financials, not a winner call.
Barinthus Biotherapeutics plc (BRNS) is a biotechnology company listed on US.
Lamb Weston Holdings Inc (LW) is a packaged foods company listed on US.
Latest reported BRNS revenue for 2025-09-30 was $0. Net income was -$14.6M. BRNS currently screens at market cap $38.2M.
Latest reported LW revenue for 2026-05-31 was $6.61B. Net income was $290.0M. Revenue was up 2.5% from 2025-05-25 to 2026-05-31. LW currently screens at market cap $7.40B and trailing P/E 20.6.
BRNS currently screens at market cap $38.2M. LW currently screens at market cap $7.40B and trailing P/E 20.6.
Not investment advice. Open the BRNS and LW stock pages for the full models.
Not investment advice.